• Co-ordinator

Approval to start clinical investigation obtained in Norway and Denmark

We are happy to announce that approvals have now been granted from both Norwegian and Danish competent authorities (Statens Legemiddelverk and Lægemiddelstyrelsen) for the SAMBAfun clinical study "A multicenter, international, open clinical investigation to evaluate the performance of a temporary epicardial pace wire with integrated sensor for continuous postoperative monitoring of myocardial function after heart surgery compared to ultrasound."

This means we are on track to enroll the first patients in August/September. This represents an important milestone both for Cardiaccs and the SAMBAfun project.

10 views0 comments

Recent Posts

See All

The first patients have been enrolled in our clinical pilot study to evaluate the performance of the temporary epicardial pace wire with integrated sensor, CardiaSense CS1, for continuous postoperativ

Ethical commitee approvals have been acheived for the study in Norway and Denmark The consortium is now planning to start the First In Man study in Q2 2021 More updates to follow